blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP4079850

EP4079850 - ANALYTICAL METHOD AND KIT [Right-click to bookmark this link]
StatusRequest for examination was made
Status updated on  23.09.2022
Database last updated on 22.08.2024
FormerThe international publication has been made
Status updated on  25.06.2021
Most recent event   Tooltip24.07.2024The date on which the examining division becomes responsible, has been established 
24.07.2024Amendment by applicant 
Applicant(s)For all designated states
KABUSHIKI KAISHA TOSHIBA
1-1, Shibaura 1-chome
Minato-ku
Tokyo
105-0023 / JP
[2022/43]
Inventor(s)01 / INADA, Mika
c/o Toshiba Corp. (K. K. TOSHIBA), 1-1, Shibaura
1-chome, Minato-ku
Tokyo 105-0023 / JP
02 / HASHIMOTO, Koji
c/o Toshiba Corp. (K. K. TOSHIBA), 1-1, Shibaura
1-chome, Minato-ku
Tokyo 105-0023 / JP
 [2022/43]
Representative(s)Marks & Clerk LLP
15 Fetter Lane
London EC4A 1BW / GB
[2022/43]
Application number, filing date20900777.211.12.2020
[2022/43]
WO2020JP46391
Priority number, dateWO2019JP4945017.12.2019         Original published format: PCT/JP2019/049450
[2022/43]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2021125105
Date:24.06.2021
Language:JA
[2021/25]
Type: A1 Application with search report 
No.:EP4079850
Date:26.10.2022
Language:EN
[2022/43]
Search report(s)International search report - published on:JP24.06.2021
(Supplementary) European search report - dispatched on:EP03.01.2024
ClassificationIPC:C12N15/09, C12Q1/68
[2022/43]
CPC:
C12Q1/6886 (EP,CN,US); C12N15/09 (EP); C12Q2600/118 (EP);
C12Q2600/158 (EP,CN); C12Q2600/178 (EP,US)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2022/43]
TitleGerman:ANALYTISCHES VERFAHREN UND KIT[2022/43]
English:ANALYTICAL METHOD AND KIT[2022/43]
French:MÉTHODE ET KIT ANALYTIQUES[2022/43]
Entry into regional phase10.09.2021Translation filed 
10.09.2021National basic fee paid 
10.09.2021Search fee paid 
10.09.2021Designation fee(s) paid 
10.09.2021Examination fee paid 
Examination procedure10.09.2021Examination requested  [2022/43]
23.07.2024Amendment by applicant (claims and/or description)
23.07.2024Date on which the examining division has become responsible
Fees paidRenewal fee
13.10.2022Renewal fee patent year 03
15.11.2023Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[A]  - SALAZAR-RUALES CAROLINA ET AL, "Salivary MicroRNAs for Early Detection of Head and Neck Squamous Cell Carcinoma: A Case-Control Study in the High Altitude Mestizo Ecuadorian Population", BIOMED RESEARCH INTERNATIONAL, vol. 2018, doi:10.1155/2018/9792730, ISSN 2314-6133, (20181121), pages 1 - 9, URL: http://downloads.hindawi.com/journals/bmri/2018/9792730.xml, XP093110477 [A] 1-30 * the whole document *

DOI:   http://dx.doi.org/10.1155/2018/9792730
International search[XYA]US2012309645  (KELLER ANDREAS [DE], et al) [X] 1-8, 12-18, 22-30 * claims * [Y] 11, 21 [A] 9-10, 19-20;
 [XYA]US2013196869  (QU KEVIN [US], et al) [X] 1-4, 13-16, 22,24, 26-28, 30 * claims, table 9 * [Y] 11, 21 [A] 5-10, 12, 17-20, 23, 25, 29;
 [XYA]US2014308674  (HAO HONGYING [US], et al) [X] 1-4, 13-16, 22,24, 26-28, 30 * claims, tables A, 6 * [Y] 11, 21 [A] 5-10, 12, 17-20, 23, 25, 29;
 [Y]JP2015039365  (TORAY INDUSTRIES, et al) [Y] 11, 21* examples *;
 [Y]JP2015051011  (NEC CORP, et al) [Y] 9, 11-14, 19,21 * claims *;
 [Y]WO2015133477  (UNIV HIROSHIMA [JP]) [Y] 10-14, 20, 21 * claims *;
 [Y]WO2015190584  (TORAY INDUSTRIES [JP], et al) [Y] 9, 11-14, 19,21 * claims, table 7 *;
 [Y]JP2016178921  (GENOMIC HEALTH INC) [Y] 9, 11-14, 19,21 * claims, table 90 *;
 [XYA]  - ZHANG, Z. et al., "Integrating MicroRNA Expression Profiling Studies to Systematically Evaluate the Diagnostic Value of MicroRNAs in Pancreatic Cancer and Validate Their Prognostic Significance with the Cancer Genome Atlas Data", Cellular Physiology and Biochemistry, (20180830), vol. 49, no. 2, pages 678 - 695, XP055836148 [X] 1-2, 4-8, 12- 18, 22-30 * , abstract, table 2, discussion * [Y] 10-14, 20-21 [A] 3, 9, 19

DOI:   http://dx.doi.org/10.1159/000493033
 [XYA]  - SONG, XIANLU et al., "miR-1301-3p promotes prostate cancer stem cell expansion by targeting SFRP1 and CSK3beta", Biomedicine & Pharmacotherapy, (20180300), vol. 99, pages 369 - 374, XP055836149 [X] 1-8, 12-18,22-30 * , abstract, page 370, right column, lines 14-26 * [Y] 9, 11-14, 19,21 [A] 10, 20
 [XYA]  - WANG, L. et al., "Serum miR-1301-3p, miR-335-5p, miR-28-5p, and their target B7-H3 may serve as novel biomarkers for colorectal cancer", JBUON, (20190501), vol. 24, no. 3, pages 1120 - 1127, XP055836139 [X] 1-8, 12-18, 22-30 * , summary, fig. 3, 4 * [Y] 11, 21 [A] 9-10, 19-20
 [XYA]  - WU, Q. et al., "EZH2 induces the expression of miR- 1301 as a negative feedback control mechanism in triple negative breast cancer", Acta Biochim Biophys Sin, (20180701), vol. 50, no. 7, pages 693 - 700, XP055836142 [X] 1-2, 4-8, 12-18, 22-30 * , abstract, fig. 1 * [Y] 11, 21 [A] 3, 9-10, 19-20

DOI:   http://dx.doi.org/10.1093/abbs/gmy050
 [XYA]  - LIANC, L. et al., "Prognostic microRNAs and their potential molecular mechanism in pancreatic cancer: A study based on The Cancer Genome Atlas and bioinformatics investigation", MOLECULAR MEDICINE REPORTS, (20180100), vol. 17, no. 1, pages 939 - 951, XP055836144 [X] 1-2, 4-8, 12-18, 22-30 * , abstract, table II, fig. 1 * [Y] 10-14, 20-21 [A] 3, 9, 19

DOI:   http://dx.doi.org/10.3892/mmr.2017.7945
 [XYA]  - FANC, L. et al., "microRNA-1301-mediated inhibition of tumorigenesis", ONCOLOCY REPORTS, (20120400), vol. 27, no. 4, pages 929 - 934, XP055836145 [X] 1-2, 4-8, 12-18, 22-30 * , abstract, introduction * [Y] 10-14, 20-21 [A] 3, 9, 19

DOI:   http://dx.doi.org/10.3892/or.2011.1589
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.